• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of shift in brain with film penetration peptide uniting enzyme for nerve type Gaucher disease treatment

Research Project

Project/Area Number 15591141
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionNippon Medical School

Principal Investigator

WATANABE Atsushi  Nippon Medical School, School of Medicine, Assistant Professor, 医学部, 助手 (10307952)

Co-Investigator(Kenkyū-buntansha) SHIMADA Takashi  Nippon Medical School, School of Medicine, Professor, 大学院・医学研究科, 教授 (20125074)
Project Period (FY) 2003 – 2004
Project Status Completed (Fiscal Year 2004)
Budget Amount *help
¥3,000,000 (Direct Cost: ¥3,000,000)
Fiscal Year 2004: ¥1,100,000 (Direct Cost: ¥1,100,000)
Fiscal Year 2003: ¥1,900,000 (Direct Cost: ¥1,900,000)
KeywordsGaucher diseas / glucocerebrosidase / penetration peptide uniting enzyme / 神経型Gaucher病 / 膜透過ペプチド / 血液脳関門 / TAT融合蛋白
Research Abstract

It is confirmed to refine the uniting protein of the eukaryocyte origin by using the appearance vector for glucocerebrosidase, and to have the enzymic activity, and a large amount of protein is made and the movement in the inside and outside of the cell is examined. The appearance plasmid is administered from mouse's coccygeal vein for a short time with the physiologic saline, the Hydrodynamic method to do the compulsion appearance by the liver chiefly is used, and the shift of the enzyme to the blood brain barrier is examined. This method is paid to attention recently because highly effective appearance is seen in easy and a short time. In addition, this.method.plasmid.enzyme.appearance.invivo.distribution.confirm.peptide.including.various.film.penetration.revitalization.element.unite.protein.brain.shift.possible. It succeeded in strong making various modification glucocerebrosidase-tat enzymes appear with the liver by using the Hydrodynamics method that was able to be administered rapidly in the vein. When the inside of the body movement had been evaluated, the shift in the brain was detected though was a small amount. It was thought that the amount and other film penetration peptide were united and a further examination was necessary in the future.

Report

(3 results)
  • 2004 Annual Research Report   Final Research Report Summary
  • 2003 Annual Research Report
  • Research Products

    (2 results)

All 2004 Other

All Journal Article (1 results) Publications (1 results)

  • [Journal Article] modification of the expression vector for systemic gene therapy of MLD2004

    • Author(s)
      Takakusaki S et al.
    • Journal Title

      Molecular Therapy 9Supple

    • Related Report
      2004 Annual Research Report
  • [Publications] Migita M., Hamada, H., Fujimura, J., Watanabe, A., Shimada, T., Fukunaga.Y.: "Glucocerebrosidase level in the cerebrospinal fluid during enzymerepla cement therapy -unsuccessful treatment to the neurological abnormality of type 2 Gaucher disease-."Eur.J.Paediatr.. 162. 524-525 (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi